Cancer News and Research

Latest Cancer News and Research

Nano Terra, Kadmon sign deal to license novel product candidates

Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra's drug discovery platform, Pharmacomer Technology.

25 Apr 2011

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

More than 1,800 Chinese oncology professionals attended the NCCN 4th Annual Asia Scientific Congress in Shanghai, China, on April 9, 2011, which featured expert faculty from NCCN Member Institutions and thought leaders in cancer care from major Chinese cancer centers.

25 Apr 2011

PVT1 gene may help reduce diabetic nephropathy

A gene called PVT1 may help reduce the kidneys ability to filter blood, leading to kidney disease, kidney failure and death, according to a study published today by researchers at the Translational Genomics Research Institute.

25 Apr 2011

Molecular Templates to present preclinical data of ETB platform technology at 5th RNAi and miRNA World Congress

Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies (ETB), announced today that it will present preclinical data in a poster presentation at the 5th Annual RNAi and miRNA World Congress in Boston, MA during April 26-27, 2011.

22 Apr 2011

JVIR articles highlight SIR's commitment to patient safety in medical imaging

The Society of Interventional Radiology has a long-term commitment to radiation safety, taking a leading role in measuring and assessing radiation dosage; developing educational programs on radiation safety, radiation protection and reduction of skin dosage; and promoting the safety of patients and health care professionals.

22 Apr 2011

Saint Vincent Hospital to build new cancer center in downtown Worcester

Saint Vincent Hospital today announced it has signed a purchase and sale agreement with the CitySquare II Development Co. LLC , to build a medical office building that will house a new comprehensive cancer center in Worcester's CitySquare development. The new center, which represents a $21 million capital investment by Saint Vincent Hospital, is expected to open in January 2013.

22 Apr 2011

Roswell Park Cancer Institute named Blue Distinction Center for Transplants

Roswell Park Cancer Institute (RPCI) has been named a Blue Distinction Center for Transplants® by BlueCross BlueShield of Western New York for demonstrating better overall quality of care and patient results in bone marrow/stem cell (autologous and allogeneic) procedures.

22 Apr 2011

Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder

Transplanting cells from healthy adult livers may work in treating a genetic liver-lung disorder that affects millions of people worldwide, according to an animal study in the April 18 online edition of the Journal of Clinical Investigation.

22 Apr 2011

HHS awards Eigen two grants from Qualifying Therapeutic Discovery Project

Eigen is the proud recipient of two grant awards from the Qualifying Therapeutic Discovery Project (QTDP) funded by the U.S. Department of Health & Human Services. QTDP tax credits are provided under section 48D of the Internal Revenue Code (IRC), enacted as part of the Patient Protection and Affordable Care Act of 2010 (P.L. 111-148).

22 Apr 2011

Research roundup: New hips, Medicare & hospital stays; Medicaid update

JAMA: Clinical Characteristics and Outcomes of Medicare Patients Undergoing Total Hip Arthroplasty, 1991-2008 - "Total hip arthroplasty is a common surgical procedure but little is known about longitudinal trends," according to this study which found that "Between 1991 and 2008, the mean age for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P < .001)."

22 Apr 2011

Digital Assent announces 100th customer of PatientPad self-service patient check-in and education solution

Just weeks after launching a national sales campaign, Digital Assent, provider of the award-winning PatientPad® self-service patient check-in and patient education solution, has signed its 100th PatientPad customer and expanded its point-of-care network to 15 states.

22 Apr 2011

State news: Calif. report faults screening of in-home care providers

Two of the state's largest private medical practices are in talks to merge into a giant doctor-run group that would care for nearly a million Massachusetts patients and significantly escalate the pace of health care consolidation throughout the state. Atrius Health, which runs the Harvard Vanguard system and four other doctors practices, is in advanced talks with Fallon Clinic, the Worcester-based medical group.

22 Apr 2011

LCA-GA calls on entire Georgia delegation to support Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance-Georgia (LCA-GA) thanked Senator Johnny Isakson (R-GA) for being an original sponsor of the Lung Cancer Mortality Reduction Act (S. 752), authorizing legislation that establishes a multi-agency, comprehensive research program addressing all aspects of lung cancer, and called on the entire delegation of Georgia to show their support for the lung cancer community.

22 Apr 2011

Idera announces delay in commencement of IMO-2125 Phase 2 clinical trial in treatment-naive HCV patients

Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.

22 Apr 2011

Research solves challenging problem of industry-scale production of large RNA molecules

Nanotechnology researchers have known for years that RNA, the cousin of DNA, is a promising tool for nanotherapy, in which therapeutic agents can be delivered inside the body via nanoparticles. But the difficulties of producing long-lasting, therapeutic RNA that remains stable and non-toxic while entering targeted cells have posed challenges for their progress.

22 Apr 2011

Atrasentan provides no additional benefits in phase III clinical trial for advanced prostate cancer

A Data and Safety Monitoring Committee (DSMC) has determined that patients in a phase III clinical trial given atrasentan in addition to a standard chemotherapy regimen for advanced prostate cancer did not have longer survival or longer progression-free survival than patients on the same chemotherapy regimen who got a placebo rather than atrasentan.

22 Apr 2011

HHS unveils new national patient safety initiative

Health and Human Services Regional Director Marguerite Salazar unveiled today a new national patient safety initiative, Partnership for Patients, on behalf of the Obama Administration at The Children's Hospital. Partnership for Patients will help save 60,000 lives across the country by stopping millions of preventable injuries and complications in patient care over the next three years.

22 Apr 2011

Loyola to honor its nurses for their commitment in clinical care, research and education

Loyola University Health System will celebrate Nurses Week from May 2 - 6. This event takes place each year just prior to May 12, the birthday of Florence Nightingale, the founder of modern nursing. The theme for the week, "Nurses Trusted to Care," reflects the confidence patients place in the hands of nurses.

22 Apr 2011

New study: Children born with HIV are now faring well into adolescence, adulthood

Once facing an almost certain death sentence, most children born with HIV are now faring well into adolescence and adulthood, according to a newly published study co-authored by Tulane infectious diseases expert Dr. Russell Van Dyke. The study was published in the Journal of Acquired Immune Deficiency Syndromes.

22 Apr 2011

DNA rearrangements in roundworm chromosomes offer insight into genome duplications in developing tumors

A study of DNA rearrangements in roundworm chromosomes may offer new insight into large-scale genome duplications that occur in developing tumors.

22 Apr 2011

Cancer News and Research

Latest Cancer News and Research

Nano Terra, Kadmon sign deal to license novel product candidates

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

PVT1 gene may help reduce diabetic nephropathy

Molecular Templates to present preclinical data of ETB platform technology at 5th RNAi and miRNA World Congress

JVIR articles highlight SIR's commitment to patient safety in medical imaging

Saint Vincent Hospital to build new cancer center in downtown Worcester

Roswell Park Cancer Institute named Blue Distinction Center for Transplants

Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder

HHS awards Eigen two grants from Qualifying Therapeutic Discovery Project

Research roundup: New hips, Medicare & hospital stays; Medicaid update

Digital Assent announces 100th customer of PatientPad self-service patient check-in and education solution

State news: Calif. report faults screening of in-home care providers

LCA-GA calls on entire Georgia delegation to support Lung Cancer Mortality Reduction Act

Idera announces delay in commencement of IMO-2125 Phase 2 clinical trial in treatment-naive HCV patients

Research solves challenging problem of industry-scale production of large RNA molecules

Atrasentan provides no additional benefits in phase III clinical trial for advanced prostate cancer

HHS unveils new national patient safety initiative

Loyola to honor its nurses for their commitment in clinical care, research and education

New study: Children born with HIV are now faring well into adolescence, adulthood

DNA rearrangements in roundworm chromosomes offer insight into genome duplications in developing tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in